UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Randomized controlled trials and real-world data: differences and similarities to untangle literature data

Rheumatology (Oxford, England), 2018-10, Vol.57 (Supplement_7), p.vii54-vii58

2018

Volltextzugriff (PDF)

Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration

Advances in therapy, 2016-03, Vol.33 (3), p.369-378

2016

Volltextzugriff (PDF)

Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc-positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study

Journal of rheumatology, 2016-05, Vol.43 (5), p.869

2016

Volltextzugriff (PDF)

Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors

Modern rheumatology, 2018-05, Vol.28 (3), p.542-549

2018

Volltextzugriff (PDF)

One year in review 2017: novelties in the treatment of rheumatoid arthritis

Clinical and experimental rheumatology, 2017-09, Vol.35 (5), p.721

2017

Volltextzugriff (PDF)

20 years of experience with tumour necrosis factor inhibitors: what have we learned?

Rheumatology (Oxford, England), 2018-10, Vol.57 (Supplement_7), p.vii5-vii10

2018

Volltextzugriff (PDF)

Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse

Rheumatology (Oxford, England), 2009-09, Vol.48 (9), p.1092-1097

2009

Volltextzugriff (PDF)

Switch or swap strategy in rheumatoid arthritis patients failing TNF inhibitors? Results of a modified Italian Expert Consensus

Rheumatology (Oxford, England), 2018-10, Vol.57 (Supplement_7), p.vii42-vii53

2018

Volltextzugriff (PDF)

Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis

Autoimmunity reviews, 2019-01, Vol.18 (1), p.93-106

2019

Volltextzugriff (PDF)

Low-dose oral prednisone improves clinical and ultrasonographic remission rates in early rheumatoid arthritis: results of a 12-month open-label randomised study

Arthritis research & therapy, 2012-05, Vol.14 (3), p.R112-R112

2012

Volltextzugriff (PDF)

COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19)

Clinical and experimental rheumatology, 2020-07, Vol.38 (4), p.748

2020

Volltextzugriff (PDF)

Glucocorticoids in Rheumatoid Arthritis

Drugs (New York, N.Y.), 2013, Vol.73 (1), p.31-43

2013

Volltextzugriff (PDF)

Switching from Intravenous to Subcutaneous Formulation of Abatacept: Different Results in a Series of 21 Patients

Journal of rheumatology, 2015-10, Vol.42 (10), p.1993

2015

Volltextzugriff (PDF)

Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs

World journal of hepatology, 2015-03, Vol.7 (3), p.344-361

2015

Volltextzugriff (PDF)

Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs

Arthritis research & therapy, 2012-02, Vol.14 (1), p.R34-R34

2012

Volltextzugriff (PDF)

Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors

Arthritis research & therapy, 2016-10, Vol.18 (1), p.242-242, Article 242

2016

Volltextzugriff (PDF)

The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts

Autoimmunity reviews, 2018-12, Vol.17 (12), p.1251-1258

2018

Volltextzugriff (PDF)

Subclinical remodelling of draining lymph node structure in early and established rheumatoid arthritis assessed by power Doppler ultrasonography

Rheumatology (Oxford, England), 2011-08, Vol.50 (8), p.1395-1400

2011

Volltextzugriff (PDF)

The role of low-dose glucocorticoids for rheumatoid arthritis in the biologic era

Clinical and experimental rheumatology, 2013-07, Vol.31 (4 Suppl 78), p.S9

2013

Volltextzugriff (PDF)

Oral Low-Dose Glucocorticoids Should Be Included in Any Recommendation for the Use of Non-Biologic and Biologic Disease-Modifying Antirheumatic Drugs in the Treatment of Rheumatoid Arthritis

Neuroimmunomodulation, 2015-01, Vol.22 (1-2), p.104-111

2015

Volltextzugriff (PDF)

Long-term methotrexate use in rheumatoid arthritis patients: real-world data from the MARTE study

Minerva medica, 2021-04, Vol.112 (2), p.246

2021

Volltextzugriff (PDF)

Recommendations for the use of biologic therapy from the Italian Society for Rheumatology: off-label use

Clinical and experimental rheumatology, 2011-05, Vol.29 (3 Suppl 66), p.S42

2011

Volltextzugriff (PDF)

Early disease control by low-dose prednisone comedication may affect the quality of remission in patients with early rheumatoid arthritis

Annals of the New York Academy of Sciences, 2010-04, Vol.1193 (1), p.139-145

2010

Volltextzugriff (PDF)

Risk of hepatitis B virus reactivation in rheumatoidarthritis patients undergoing biologic treatment： Extendingperspective from old to newer drugs

世界肝病学杂志：英文版（电子版）, 2015 (3), p.344-361

Francesca De Nard Monica Todoerti Vittorio Grosso Sara Monti Silvia Breda Silvia Rossi Carlomaurizio Montecucco Roberto Caporali

2015

Volltextzugriff (PDF)

Biosimilars: lights and shadows in rheumatology

Rheumatology reports, 2014-11, Vol.6 (1)

2014

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Humans
(29)
Arthritis, Rheumatoid - Drug Therapy
(17)
Rheumatology
(17)
Female
(14)
Male
(14)
Rheumatoid Arthritis
(14)
Antirheumatic Agents - Therapeutic Use
(12)
Aged
(10)
Middle Aged
(10)
Treatment Outcome
(8)
Antirheumatic Agents - Adverse Effects
(6)
Hematology
(6)
Antirheumatic Agents - Administration & Dosage
(5)
Arthritis
(5)
Arthritis, Rheumatoid - Diagnosis
(5)
Italy
(5)
Oncology
(5)
Adult
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized controlled trials and real-world data: differences and similarities to untangle literature data

Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration

Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc-positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study

Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors

One year in review 2017: novelties in the treatment of rheumatoid arthritis

20 years of experience with tumour necrosis factor inhibitors: what have we learned?

Ultrasonographic evaluation of joint involvement in early rheumatoid arthritis in clinical remission: power Doppler signal predicts short-term relapse

Switch or swap strategy in rheumatoid arthritis patients failing TNF inhibitors? Results of a modified Italian Expert Consensus

Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis

Low-dose oral prednisone improves clinical and ultrasonographic remission rates in early rheumatoid arthritis: results of a 12-month open-label randomised study

COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19)

Glucocorticoids in Rheumatoid Arthritis

Switching from Intravenous to Subcutaneous Formulation of Abatacept: Different Results in a Series of 21 Patients

Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs

Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs

Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors

The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts

Subclinical remodelling of draining lymph node structure in early and established rheumatoid arthritis assessed by power Doppler ultrasonography

The role of low-dose glucocorticoids for rheumatoid arthritis in the biologic era

Oral Low-Dose Glucocorticoids Should Be Included in Any Recommendation for the Use of Non-Biologic and Biologic Disease-Modifying Antirheumatic Drugs in the Treatment of Rheumatoid Arthritis

Long-term methotrexate use in rheumatoid arthritis patients: real-world data from the MARTE study

Recommendations for the use of biologic therapy from the Italian Society for Rheumatology: off-label use

Early disease control by low-dose prednisone comedication may affect the quality of remission in patients with early rheumatoid arthritis

Risk of hepatitis B virus reactivation in rheumatoidarthritis patients undergoing biologic treatment： Extendingperspective from old to newer drugs

Biosimilars: lights and shadows in rheumatology

Suchergebnisse filtern